| Guardant Health, Inc. | 16,927 | US$2.54M | 9.1% |
| Natera, Inc. | 7,679 | US$2.08M | 7.5% |
| Krystal Biotech, Inc. | 4,757 | US$1.77M | 6.3% |
| Ligand Pharmaceuticals Incorporated | 4,085 | US$1.29M | 4.6% |
| Adaptive Biotechnologies Corporation | 51,956 | US$1.11M | 4.0% |
| United Therapeutics Corporation | 1,809 | US$980K | 3.5% |
| Bridgebio Pharma, Inc. | 13,129 | US$978K | 3.5% |
| Eli Lilly And Company | 688 | US$825K | 3.0% |
| Twist Bioscience Corporation | 7,736 | US$796K | 2.8% |
| Vertex Pharmaceuticals Incorporated | 1,545 | US$767K | 2.7% |
| Astrazeneca Plc | 3,979 | US$754K | 2.7% |
| Travere Therapeutics, Inc. | 12,753 | US$724K | 2.6% |
| Insmed Incorporated | 6,388 | US$681K | 2.4% |
| Samsung Biologics Co., Ltd. | 702 | US$630K | 2.3% |
| Corteva, Inc. | 7,435 | US$630K | 2.3% |
| Medpace Holdings, Inc. | 1,133 | US$600K | 2.1% |
| Alnylam Pharmaceuticals, Inc. | 1,816 | US$547K | 2.0% |
| Tempus Ai, Inc. | 9,397 | US$544K | 1.9% |
| Ionis Pharmaceuticals, Inc. | 6,739 | US$534K | 1.9% |
| Neurocrine Biosciences, Inc. | 3,058 | US$515K | 1.8% |
| Regeneron Pharmaceuticals, Inc. | 805 | US$502K | 1.8% |
| Veracyte, Inc. | 7,819 | US$459K | 1.6% |
| Argenx Se | 457 | US$458K | 1.6% |
| Ptc Therapeutics, Inc. | 5,009 | US$409K | 1.5% |
| Stoke Therapeutics, Inc. | 11,349 | US$371K | 1.3% |
| Charles River Laboratories International, Inc. | 1,556 | US$353K | 1.3% |
| Grail, Inc. | 4,456 | US$304K | 1.1% |
| Anaptysbio, Inc. | 4,290 | US$290K | 1.0% |
| Crispr Therapeutics Ag | 5,030 | US$274K | 0.98% |
| Repligen Corporation | 2,009 | US$274K | 0.98% |
| Cadence Design Systems, Inc. | 725 | US$272K | 0.97% |
| Beam Therapeutics Inc. | 7,577 | US$260K | 0.93% |
| Praxis Precision Medicines, Inc. | 718 | US$240K | 0.86% |
| Axsome Therapeutics, Inc. | 936 | US$229K | 0.82% |
| Caredx, Inc. | 8,000 | US$228K | 0.82% |
| Jazz Pharmaceuticals Plc | 905 | US$218K | 0.78% |
| Catalyst Pharmaceuticals, Inc. | 6,865 | US$216K | 0.77% |
| Thermo Fisher Scientific Inc | 421 | US$211K | 0.76% |
| Iqvia Holdings, Inc. | 1,082 | US$209K | 0.75% |
| Hinge Health, Inc. | 2,349 | US$195K | 0.70% |
| Ultragenyx Pharmaceutical Inc. | 5,131 | US$171K | 0.61% |
| Agilent Technologies, Inc. | 1,223 | US$162K | 0.58% |
| Danaher Corporation | 842 | US$160K | 0.57% |
| Qiagen N.v. | 3,419 | US$134K | 0.48% |
| Rhythm Pharmaceuticals, Inc. | 1,048 | US$116K | 0.42% |
| Arcutis Biotherapeutics, Inc. | 4,422 | US$116K | 0.42% |
| Samsung Epis Holdings Co., Ltd. | 376 | US$104K | 0.37% |
| Kiniksa Pharmaceuticals International, Plc | 1,479 | US$94,582 | 0.34% |
| Tarsus Pharmaceuticals, Inc. | 1,136 | US$71,500 | 0.26% |
| Bio-rad Laboratories, Inc. | 243 | US$71,347 | 0.26% |
| Liquidia Corporation | 871 | US$69,445 | 0.25% |
| Bristol-myers Squibb Company | 1,196 | US$68,914 | 0.25% |
| Tg Therapeutics, Inc. | 1,253 | US$68,840 | 0.25% |
| Beone Medicines Ltd. Class A | 225 | US$64,118 | 0.23% |
| Neurogene Inc. | 1,981 | US$62,302 | 0.22% |
| First Tracks Biotherapeutics, Inc. | 2,775 | US$55,833 | 0.20% |
| Genedx Holdings Corp. | 575 | US$39,474 | 0.14% |
| Wave Life Sciences Ltd. | 4,813 | US$27,964 | 0.10% |
| Recursion Pharmaceuticals, Inc. | 5,507 | US$20,211 | 0.07% |
| Transmedics Group, Inc. | 0 | US$0 | 0.00% |
| Caris Life Sciences, Inc. | 0 | US$0 | 0.00% |